SARS‐CoV‐2 vaccination and infection in ozanimod‐treated participants with relapsing multiple sclerosis

OBJECTIVE: To investigate the serologic response, predictors of response, and clinical outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination and infection in ozanimod‐treated participants with relapsing multiple sclerosis (RMS) from DAYBREAK. METHODS: DAYB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cree, Bruce A. C., Maddux, Rachel, Bar‐Or, Amit, Hartung, Hans‐Peter, Kaur, Amandeep, Brown, Elizabeth, Li, Yicong, Hu, Yanhua, Sheffield, James K., Silva, Diego, Harris, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578897/
https://www.ncbi.nlm.nih.gov/pubmed/37550942
http://dx.doi.org/10.1002/acn3.51862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578897/
https://www.ncbi.nlm.nih.gov/pubmed/37550942
http://dx.doi.org/10.1002/acn3.51862

Ejemplares similares